trimethoprim, sulfadoxine drug combination has been researched along with P carinii Pneumonia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckerich, F; Botterel, F; Cabanne, L; Cordonnier, C; di Blasi, R; Foulet, F; Leclerc, M; Maury, S; Pautas, C; Redjoul, R; Robin, C; Toma, A | 1 |
| Best, MP; Boyd, SP; Danesi, P | 1 |
| Abe, D; Iseki, T; Kawaguchi, T; Muto, T; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Takeda, Y; Takeuchi, M; Tanaka, S; Tsukamoto, S; Yokote, K | 1 |
| Baluarte, HJ; Bergqvist, AG; Ganesh, J; Heltzer, M; Keller, MD; Orange, JS; Paessler, M; Rosenblatt, DS; Watkins, D | 1 |
4 other study(ies) available for trimethoprim, sulfadoxine drug combination and P carinii Pneumonia
| Article | Year |
|---|---|
Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?
Topics: Adult; Aged; Allografts; Atovaquone; Drug Combinations; Female; Follow-Up Studies; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Sulfadoxine; Trimethoprim | 2019 |
Confirmed case of Pneumocystis pneumonia in a Maltese Terrier × Papillon dog being treated with toceranib phosphate.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Female; Indoles; Mast-Cell Sarcoma; Pneumonia, Pneumocystis; Pyrroles; Sulfadoxine; Treatment Outcome; Trimethoprim | 2019 |
Low-dose trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT.
Topics: Adolescent; Adult; Anti-Infective Agents; Drug Combinations; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Sulfadoxine; Transplantation, Homologous; Trimethoprim | 2011 |
Severe combined immunodeficiency resulting from mutations in MTHFD1.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Anemia, Megaloblastic; Bone Marrow Examination; Cardiomyopathies; Combined Modality Therapy; DNA Mutational Analysis; Drug Combinations; Drug Therapy, Combination; Exome; Female; Genetic Carrier Screening; Humans; Hydroxocobalamin; Immunization, Passive; Infant; Infant, Newborn; Leukopenia; Lipid Metabolism, Inborn Errors; Methylenetetrahydrofolate Dehydrogenase (NADP); Minor Histocompatibility Antigens; Mitochondrial Myopathies; Mitochondrial Trifunctional Protein; Nervous System Diseases; Opportunistic Infections; Peripheral Nervous System Diseases; Pneumonia, Pneumocystis; Retinitis Pigmentosa; Rhabdomyolysis; Sequence Analysis, DNA; Severe Combined Immunodeficiency; Sulfadoxine; Trimethoprim; Vitamin B 12 | 2013 |